Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Sep 17;56(3):2002114.
doi: 10.1183/13993003.02114-2020. Print 2020 Sep.

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network

Silke van Koningsbruggen-Rietschel  1 , Fiona Dunlevy  2 , Veerle Bulteel  2 , Damian G Downey  3 , Lieven Dupont  4
Affiliations
Comment

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network

Silke van Koningsbruggen-Rietschel et al. Eur Respir J. .

Abstract

Rare disease patients may suffer delayed access to new drugs as SARS-CoV-2 is disrupting clinical trials. This survey demonstrates that the European Cystic Fibrosis Clinical Trials Network is ideally placed to track and address such disruption. https://bit.ly/3hCw5dq

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: S. van Koningsbruggen-Rietschel reports grants from Algipharma (HORIZON2020), personal fees from Deutsches Zentrum für Infektionsforschung, Antabio, Proteostasis Therapeutics, Roche and Vertex Pharmaceuticals, outside the submitted work. Conflict of interest: F. Dunlevy has nothing to disclose. Conflict of interest: V. Bulteel has nothing to disclose. Conflict of interest: D.G. Downey reports grants and personal fees from Vertex, Proteostasis and Chiesi, outside the submitted work. Conflict of interest: L. Dupont has nothing to disclose.

Comment on

References

    1. McDermott MM, Newman AB. Preserving clinical trial integrity during the coronavirus pandemic. JAMA 2020; 323: 2135–2136. - PubMed
    1. Shteinberg M, Taylor-Cousar JL. Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease. Eur Respir Rev 2020; 29: 190112. doi:10.1183/16000617.0112-2019 - DOI - PMC - PubMed
    1. Food and Drug Administration . FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. www.fda.gov/media/136238/downloadDate last updated: 14 May 2020. Date last accessed: 15 May 2020.
    1. European Medicines Agency . Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic. www.ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/guidanc...Date last updated: 28 April 2020. Date last accessed: 15 May 2020.
    1. De Boeck K, Bulteel V, Fajac I. Disease-specific clinical trials networks: the example of cystic fibrosis. Eur J Pediatr 2016; 175: 817–824. doi:10.1007/s00431-016-2712-z - DOI - PMC - PubMed

LinkOut - more resources